180 related articles for article (PubMed ID: 38094583)
1. Identification of novel serum protein biomarkers in the context of 3P medicine for intravenous leiomyomatosis: a data-independent acquisition mass spectrometry-based proteomics study.
Ge Z; Feng P; Zhang Z; Liang Z; Chen R; Li J
EPMA J; 2023 Dec; 14(4):613-629. PubMed ID: 38094583
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel Serum Metabolic Biomarkers as Indicators in the Progression of Intravenous Leiomyomatosis: A High Performance Liquid Chromatography-Tandem Mass Spectrometry-Based Study.
Ge Z; Feng P; Zhang Z; Li J; Yu Q
Front Cell Dev Biol; 2021; 9():695540. PubMed ID: 34307370
[TBL] [Abstract][Full Text] [Related]
3. Identification of the molecular relationship between intravenous leiomyomatosis and uterine myoma using RNA sequencing.
Zhang X; Wu L; Xu R; Zhu C; Ma G; Zhang C; Liu X; Zhao H; Miao Q
Sci Rep; 2019 Feb; 9(1):1442. PubMed ID: 30723247
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitinomics revealed disease- and stage-specific patterns relevant for the 3PM approach in human sigmoid colon cancers.
Yang H; Li N; Chen L; Zhou L; Zhou Y; Liu J; Jia W; Chen R; Su J; Yang L; Gong X; Zhan X
EPMA J; 2023 Sep; 14(3):503-525. PubMed ID: 37605648
[TBL] [Abstract][Full Text] [Related]
5. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach.
Zhang Y; Li N; Yang L; Jia W; Li Z; Shao Q; Zhan X
EPMA J; 2023 Sep; 14(3):477-502. PubMed ID: 37605650
[TBL] [Abstract][Full Text] [Related]
6. Intravenous leiomyomatosis is inclined to a solid entity different from uterine leiomyoma based on RNA-seq analysis with RT-qPCR validation.
Wang W; Wang Y; Chen F; Zhang M; Jia R; Liu X; Zhang C; Shao J; Cheng N; Ma G; Zhu Z; Miao Q; Liang Z
Cancer Med; 2020 Jul; 9(13):4581-4592. PubMed ID: 32372565
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential necroinflammation-associated necroptosis-related biomarkers for delayed graft function and renal allograft failure: a machine learning-based exploration in the framework of predictive, preventive, and personalized medicine.
Bi Q; Wu JY; Qiu XM; Li YQ; Yan YY; Sun ZJ; Wang W
EPMA J; 2023 Jun; 14(2):307-328. PubMed ID: 37275548
[TBL] [Abstract][Full Text] [Related]
8. MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study.
Wang L; Hu S; Xin F; Zhao H; Li G; Ran W; Xing X; Wang J
Hum Pathol; 2020 May; 99():36-42. PubMed ID: 32240666
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer.
Lu M; Zhan H; Liu B; Li D; Li W; Chen X; Zhou X
EPMA J; 2021 Dec; 12(4):589-604. PubMed ID: 34950253
[TBL] [Abstract][Full Text] [Related]
10. TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine.
Zhang S; Wan X; Lv M; Li C; Chu Q; Wang G
EPMA J; 2022 Sep; 13(3):519-534. PubMed ID: 36061829
[TBL] [Abstract][Full Text] [Related]
11. Management and prognosis comparison between incidental and nonincidental intravenous leiomyomatosis: a retrospective single-center real-life experience.
Shi P; Xiao H; Li H; Tang W; Ren A; Ma L; Tu R; Yin S; Zhang J
Ann Transl Med; 2022 May; 10(9):503. PubMed ID: 35692495
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of pretreatment red blood cell distribution width in primary diffuse large B-cell lymphoma of the central nervous system for 3P medical approaches in multiple cohorts.
Li D; Li S; Xia Z; Cao J; Zhang J; Chen B; Zhang X; Zhu W; Fang J; Liu Q; Hua W
EPMA J; 2022 Sep; 13(3):499-517. PubMed ID: 36061828
[TBL] [Abstract][Full Text] [Related]
13. Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative omics approaches and machine-learning strategies.
Yang F; Wendusubilige ; Kong J; Zong Y; Wang M; Jing C; Ma Z; Li W; Cao R; Jing S; Gao J; Li W; Wang J
EPMA J; 2023 Sep; 14(3):417-442. PubMed ID: 37605652
[TBL] [Abstract][Full Text] [Related]
14. Predicting 1-, 3-, 5-, and 8-year all-cause mortality in a community-dwelling older adult cohort: relevance for predictive, preventive, and personalized medicine.
Chen Y; Deng X; Lin D; Yang P; Wu S; Wang X; Zhou H; Chen X; Wang X; Wu W; Ke K; Huang W; Tan X
EPMA J; 2023 Dec; 14(4):713-726. PubMed ID: 38094581
[TBL] [Abstract][Full Text] [Related]
15. Molecular and clinicopathologic characterization of intravenous leiomyomatosis.
Ordulu Z; Chai H; Peng G; McDonald AG; De Nictolis M; Garcia-Fernandez E; Hardisson D; Prat J; Li P; Hui P; Oliva E; Buza N
Mod Pathol; 2020 Sep; 33(9):1844-1860. PubMed ID: 32341498
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of 81 cases of intravenous leiomyomatosis confined to pelvic cavity].
Xia XL; Li JQ; Lin J
Zhonghua Fu Chan Ke Za Zhi; 2022 Jan; 57(1):39-45. PubMed ID: 35090244
[No Abstract] [Full Text] [Related]
17. Diagnostic experience of intravenous leiomyomatosis with emphasis on conventional ultrasonography imaging: a single-center study.
Ge Z; Wang Y; Wang Y; Li W; Yang X; Li J; Wang H
Front Oncol; 2023; 13():1203591. PubMed ID: 37492474
[TBL] [Abstract][Full Text] [Related]
18. [Expression characteristics and diagnostic value of angiogenic molecules in intravenous leiomyomatosis].
Sun LJ; Zhou F; Benjoed BENJOED; Zhu CK; Lyu WG; Li Y
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(26):2005-2010. PubMed ID: 35817725
[No Abstract] [Full Text] [Related]
19. Blood transcriptome profiling as potential biomarkers of suboptimal health status: potential utility of novel biomarkers for predictive, preventive, and personalized medicine strategy.
Wang H; Tian Q; Zhang J; Liu H; Zhang J; Cao W; Zhang X; Li X; Wu L; Song M; Kong Y; Wang W; Wang Y
EPMA J; 2021 Jun; 12(2):103-115. PubMed ID: 34194583
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and clinical outcomes of intravenous leiomyomatosis of the uterus: A case series.
Yu X; Fu J; Cao T; Huang L; Qie M; Ouyang Y
Medicine (Baltimore); 2021 Jan; 100(1):e24228. PubMed ID: 33429819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
